A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
|ClinicalTrials.gov Identifier: NCT01146574|
Recruitment Status : Completed
First Posted : June 17, 2010
Last Update Posted : March 8, 2017
Acceleron Pharma, Inc.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||March 7, 2016|
|Actual Study Completion Date :||March 7, 2016|
|Certification/Extension First Submitted :||March 7, 2017|